- Home
- VKTX vs PBH Comparison
VKTX vs PBH Comparison
Compare VKTX & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- PBH
- Stock Information
- Founded
- VKTX 2012
- PBH 1996
- Country
- VKTX United States
- PBH United States
- Employees
- VKTX N/A
- PBH N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- PBH Biotechnology: Pharmaceutical Preparations
- Sector
- VKTX Health Care
- PBH Health Care
- Exchange
- VKTX Nasdaq
- PBH Nasdaq
- Market Cap
- VKTX 3.5B
- PBH 3.8B
- IPO Year
- VKTX 2015
- PBH 2005
- Fundamental
- Price
- VKTX $40.03
- PBH $64.98
- Analyst Decision
- VKTX Strong Buy
- PBH Buy
- Analyst Count
- VKTX 13
- PBH 5
- Target Price
- VKTX $86.92
- PBH $94.00
- AVG Volume (30 Days)
- VKTX 4.6M
- PBH 526.0K
- Earning Date
- VKTX 07-23-2025
- PBH 08-07-2025
- Dividend Yield
- VKTX N/A
- PBH N/A
- EPS Growth
- VKTX N/A
- PBH 4.18
- EPS
- VKTX N/A
- PBH 4.26
- Revenue
- VKTX N/A
- PBH $1,120,150,000.00
- Revenue This Year
- VKTX N/A
- PBH $2.04
- Revenue Next Year
- VKTX $338.60
- PBH $2.07
- P/E Ratio
- VKTX N/A
- PBH $15.38
- Revenue Growth
- VKTX N/A
- PBH 0.63
- 52 Week Low
- VKTX $18.92
- PBH $62.95
- 52 Week High
- VKTX $81.73
- PBH $90.04
- Technical
- Relative Strength Index (RSI)
- VKTX 69.97
- PBH 27.19
- Support Level
- VKTX $39.35
- PBH $64.01
- Resistance Level
- VKTX $41.68
- PBH $66.57
- Average True Range (ATR)
- VKTX 2.06
- PBH 2.22
- MACD
- VKTX 0.56
- PBH -0.66
- Stochastic Oscillator
- VKTX 84.10
- PBH 14.76
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.